Apart from well-known value as an adiposity biomarker (Rodríguez-Calvo et al., 2017), elevated FABP4 serum concentration on the background of obesity and metabolic syndrome could be also due to it’s high expression in the liver. This evidence concerns the gene FABP4 and obesity due to melanocortin 4 receptor deficiency.